Skip to Content

MD Anderson Events

22nd Melvin L. Samuels Lectureship

22nd Melvin L. Samuels Lectureship

Speaker: Robert Schreiber, Ph.D.

AM Bursky & JM Bursky Distinguished Professor, Department of Immunology 

Washingtong University Center fo Human Immunology and Immunotherapy Programs

Date: June 8

Location: Onstead Auditorium, BSRB3.8012


Host: GU Medical Oncology

Date: 6/8/18, 10am to 11am
Time: 6/8/18, 10am to 11am
Location: Onstead Auditorium, Basic Science Research Building, Floor 3, near Elevator J, (S3.8012)
Format: Seminar/Conference
Speaker: Robert Schreiber, Ph.D.
Speaker Bio: Bio:Richard D. Schreiber, is the Andrew M. and Jane M. Bursky Distinguished Professor in the Department of Pathology and Immunology and Professor of Molecular Microbiology at Washington University School of Medicine in St. Louis. He is co-leader of the Tumor Immunology Program of Washington's University Siteman Comprehensive Cancer Center, and the founding director of the Andrew M and Jane M Bursky Center for Human Immunology and Immunotherapy Programs. Dr. Schreiber is an Extramural Member Researched of the Parker Institute for Cancer Immunotherapy, an Associate Director of the Scientific Advisory Board to the Cancer Research Institute, and a member of the Board of Scientific Advisors to the National Cancer Institute. Dr. Schreiber's career has focused on elucidating the biochemistry and molecular cell biology of cytokines and defining the role they play in promoting immune responses to cancer. Dr. Schreiber pioneered the use of genomics approaches to define the antigenic targets of cancer immunoediting and elucidate the mechanisms that underlie the process. Dr. Schreiber has authored more than 300 peer reviewed and invited publications and has received many honors including the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute, the Charles Rodolphe Brupbacher Prize for Cancer Research, the Lloyd J. Old Prize in Cancer Immunology awarded jointly by the American Association for Cancer Research and the Cancer Research Institute and the Balzan Prize (Shared with Dr. James Allison): Immunological Approaches in Cancer Therapy. Dr. Schreiber is a Fellow of the American Association for the Advancement of Science, a member of the American Academy of Arts and Sciences and a member of the U.S. National Academy of Sciences.
Contact: Tiffany Razzo - (713) 792-9859 -